Market Closed -
Nasdaq
04:00:00 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
42.8
USD
|
+3.13%
|
|
-4.93%
|
+608.61%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
353.1
|
105
|
77.1
|
13.84
|
26.72
|
457.4
|
-
|
-
|
Enterprise Value (EV)
1 |
353.1
|
105
|
77.1
|
13.84
|
26.72
|
457.4
|
457.4
|
457.4
|
P/E ratio
|
-4.88
x
|
-0.88
x
|
-1.66
x
|
-0.33
x
|
-0.59
x
|
-7.3
x
|
-7.37
x
|
-3.98
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.77
x
|
26.7
x
|
87.4
x
|
-
|
-
|
-
|
137
x
|
54.9
x
|
EV / Revenue
|
9.77
x
|
26.7
x
|
87.4
x
|
-
|
-
|
-
|
137
x
|
54.9
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-7.29
x
|
-1.05
x
|
-1.6
x
|
-0.37
x
|
-
|
-13.4
x
|
-14.4
x
|
-14.3
x
|
FCF Yield
|
-13.7%
|
-95.4%
|
-62.6%
|
-271%
|
-
|
-7.45%
|
-6.95%
|
-7%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
2,156
|
2,801
|
4,174
|
4,176
|
4,424
|
10,687
|
-
|
-
|
Reference price
2 |
163.8
|
37.50
|
18.47
|
3.315
|
6.040
|
42.80
|
42.80
|
42.80
|
Announcement Date
|
3/12/20
|
3/15/21
|
3/8/22
|
3/7/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
36.14
|
3.937
|
0.8817
|
-
|
-
|
-
|
3.333
|
8.333
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-77.1
|
-122.8
|
-55.99
|
-39.84
|
-45.08
|
-51.36
|
-61.75
|
-87.49
|
Operating Margin
|
-213.33%
|
-3,119.2%
|
-6,350.05%
|
-
|
-
|
-
|
-1,852.62%
|
-1,049.89%
|
Earnings before Tax (EBT)
1 |
-71.45
|
-111.3
|
-45.64
|
-42.35
|
-44.6
|
-50.86
|
-69.49
|
-102.1
|
Net income
1 |
-71.45
|
-111.3
|
-45.64
|
-42.35
|
-44.6
|
-49.51
|
-69.49
|
-102.1
|
Net margin
|
-197.69%
|
-2,826.08%
|
-5,176.35%
|
-
|
-
|
-
|
-2,084.76%
|
-1,225.4%
|
EPS
2 |
-33.60
|
-42.60
|
-11.10
|
-10.15
|
-10.31
|
-5.860
|
-5.805
|
-10.76
|
Free Cash Flow
1 |
-48.46
|
-100.2
|
-48.24
|
-37.56
|
-
|
-34.09
|
-31.8
|
-32.01
|
FCF margin
|
-134.09%
|
-2,544.18%
|
-5,470.95%
|
-
|
-
|
-
|
-953.88%
|
-384.13%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/12/20
|
3/15/21
|
3/8/22
|
3/7/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-9.998
|
-8.517
|
-12.34
|
-8.181
|
-10.8
|
-17.3
|
-8.189
|
-9.488
|
-10.1
|
-9.623
|
-13.01
|
-14.02
|
-14.76
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-10.26
|
-9.437
|
-13.25
|
-8.782
|
-10.88
|
-17.74
|
-8.784
|
-10.05
|
-8.021
|
-6.899
|
-11.84
|
-14.51
|
-16.32
|
-
|
-
|
Net income
1 |
-10.26
|
-9.437
|
-13.25
|
-8.782
|
-10.88
|
-17.74
|
-8.784
|
-10.05
|
-8.021
|
-6.899
|
-11.84
|
-14.51
|
-16.32
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-2.400
|
-2.400
|
-3.300
|
-2.100
|
-2.610
|
-4.240
|
-2.050
|
-2.270
|
-1.810
|
-0.8300
|
-1.405
|
-1.710
|
-1.895
|
-1.240
|
-1.230
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/8/22
|
5/10/22
|
8/9/22
|
11/8/22
|
3/7/23
|
5/9/23
|
8/8/23
|
11/7/23
|
3/12/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-48.5
|
-100
|
-48.2
|
-37.6
|
-
|
-34.1
|
-31.8
|
-32
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
2.74
|
0.48
|
0.05
|
0.01
|
-
|
0.04
|
0.04
|
0.05
|
Capex / Sales
|
7.59%
|
12.31%
|
6.14%
|
-
|
-
|
-
|
1.23%
|
0.54%
|
Announcement Date
|
3/12/20
|
3/15/21
|
3/8/22
|
3/7/23
|
3/12/24
|
-
|
-
|
-
|
Last Close Price
42.8
USD Average target price
71
USD Spread / Average Target +65.89% Consensus |
1st Jan change
|
Capi.
|
---|
| +608.61% | 457M | | +11.91% | 118B | | +11.60% | 106B | | -4.68% | 24.28B | | -0.82% | 21.96B | | -10.12% | 18.16B | | -42.12% | 16.37B | | -17.47% | 15.56B | | +2.77% | 13.63B | | +34.58% | 12.27B |
Bio Therapeutic Drugs
|